10
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Behavioural Response Alteration in Caenorhabditis elegans to Urine After Surgical Removal of Cancer: Nematode-NOSE (N-NOSE) for Postoperative Evaluation

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The technique used for cancer monitoring is essential for effective cancer therapy. Currently, several methods such as diagnostic imaging and biochemical markers have been used for cancer monitoring, but these are invasive and show low sensitivity. A previous study reported that Caenorhabditis elegans sensitively discriminated patients with cancer from healthy subjects, based on the smell of a urine sample. However, whether C. elegans olfaction can detect the removal of cancerous tumours remains unknown. This study was conducted to examine C. elegans olfactory behaviour to urine samples collected from 78 patients before and after surgery. The diagnostic ability of the technique termed Nematode-NOSE (N-NOSE) was evaluated by receiver operating characteristic (ROC) analysis. The ROC curve of N-NOSE was higher than those of classic tumour markers. Furthermore, we examined the change in C. elegans olfactory behaviour following exposure to preoperative and postoperative samples. The results suggest that a reduction in attraction indicates the removal of the cancerous tumour. This study may lead to the development of a noninvasive and highly sensitive tool for evaluating postoperative cancer patients.

          Related collections

          Most cited references25

          • Record: found
          • Abstract: found
          • Article: not found

          A subpopulation of CD26+ cancer stem cells with metastatic capacity in human colorectal cancer.

          Recent evidence suggests that a subpopulation of cancer cells, cancer stem cells (CSCs), is responsible for tumor growth in colorectal cancer. However, the role of CSCs in colorectal cancer metastasis is unclear. Here, we identified a subpopulation of CD26(+) cells uniformly present in both the primary and metastatic tumors in colorectal cancer patients with liver metastasis. Furthermore, in patients without distant metastasis at the time of presentation, the presence of CD26(+) cells in their primary tumors predicted distant metastasis on follow-up. Isolated CD26(+) cells, but not CD26(-) cells, led to development of distant metastasis when injected into the mouse cecal wall. CD26(+) cells were also associated with enhanced invasiveness and chemoresistance. Our findings have uncovered a critical role of CSCs in metastatic progression of cancer. Furthermore, the ability to predict metastasis based on analysis of CSC subsets in the primary tumor may have important clinical implication as a selection criterion for adjuvant therapy. Copyright 2010 Elsevier Inc. All rights reserved.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            The scent of disease: volatile organic compounds of the human body related to disease and disorder.

            Hundreds of volatile organic compounds (VOCs) are emitted from the human body, and the components of VOCs usually reflect the metabolic condition of an individual. Therefore, contracting an infectious or metabolic disease often results in a change in body odour. Recent progresses in analytical techniques allow rapid analyses of VOCs derived from breath, blood, skin and urine. Disease-specific VOCs can be used as diagnostic olfactory biomarkers of infectious diseases, metabolic diseases, genetic disorders and other kinds of diseases. Elucidation of pathophysiological mechanisms underlying production of disease-specific VOCs may provide novel insights into therapeutic approaches for treatments for various diseases. This review summarizes the current knowledge on chemical and clinical aspects of body-derived VOCs, and provides a brief outlook at the future of olfactory diagnosis.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Blood CEA levels for detecting recurrent colorectal cancer.

              Testing for carcino-embryonic antigen (CEA) in the blood is a recommended part of follow-up to detect recurrence of colorectal cancer following primary curative treatment. There is substantial clinical variation in the cut-off level applied to trigger further investigation.
                Bookmark

                Author and article information

                Journal
                Biomark Cancer
                Biomark Cancer
                BIC
                spbic
                Biomarkers in Cancer
                SAGE Publications (Sage UK: London, England )
                1179-299X
                24 December 2019
                2019
                : 11
                : 1179299X19896551
                Affiliations
                [1 ]Department of Gastroenterology, Nanpuh Hospital, Kagoshima, Japan
                [2 ]Department of Gastrointestinal Surgery, Nanpuh Hospital, Kagoshima, Japan
                [3 ]Department of Diagnostic Pathology, Nanpuh Hospital, Kagoshima, Japan
                [4 ]R&D Center, Hirotsu Bio Science Inc., Tokyo, Japan
                [5 ]Department of Biology, Graduate School of Sciences, Kyushu University, Fukuoka, Japan
                [6 ]School of Biomedical Sciences, Faculty of Health, Queensland University of Technology, Brisbane, QLD, Australia
                Author notes
                [*]Toru Niihara, Department of Gastroenterology, Nanpuh Hospital, 14-3 Nagata-cho, Kagoshima 892-8512, Japan. Email: t.niihara@ 123456nanpuh.or.jp
                [*]Takayuki Uozumi, Hirotsu Bio Science Inc., 2-24-11, Minami-Aoyama, Minatoku, Tokyo 107-0062, Japan. Email: uozumi@ 123456hbio.jp
                Author information
                https://orcid.org/0000-0002-6107-3452
                Article
                10.1177_1179299X19896551
                10.1177/1179299X19896551
                6931140
                52c2d0e6-f3b9-4bdc-8ef9-1e3d170e8be9
                © The Author(s) 2019

                This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License ( https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages ( https://us.sagepub.com/en-us/nam/open-access-at-sage).

                History
                : 12 November 2019
                : 26 November 2019
                Categories
                Original Research
                Custom metadata
                January-December 2019
                ts1

                caenorhabditis elegans,olfaction,cancer,prognosis,biodiagnosis

                Comments

                Comment on this article